Wu W M, Pop E, Shek E, Bodor N
Center for Drug Design and Delivery, J. Hillis Miller Health Center, College of Pharmacy, University of Florida, Gainesville 32610.
J Med Chem. 1989 Aug;32(8):1782-8. doi: 10.1021/jm00128a020.
Four chemical delivery systems (CDS's) based on a dihydropyridine----quaternary pyridinium salt redox system were used for the brain delivery of benzylpenicillin (BP). CDS's 5 and 9 are diesters of C1 and C2 diols in which one hydroxyl group is esterified by the benzylpenicillin-3-carboxylic group and the other by dihydrotrigonelline. CDS's 13a and 17 are benzylpenicillin esters of amino alcohols in which the amine group is acylated by dihydro-trigonelline (13a) or by 1,2-dihydro-2-methyl-4-isoquinolinecarboxylic acid (17). In vitro relative stability studies showed that both CDS's and quaternary pyridinium salts were quite unstable in rat and rabbit blood or brain but much more stable in dog or human blood. Kinetic studies performed in rat brain homogenate demonstrated the facile enzymatic oxidation of the CDS's to the corresponding quaternary salts. Hydrolysis of the CDS's and the quaternary salts resulted in the release of benzylpenicillin. In biological media CDS 13a also yielded a water addition product, the 6-hydroxy-1,4,5,6-tetrahydropyridine derivative. In vivo distribution studies were carried out in rats. After iv administration of equimolar doses of BP and CDS's, brain benzylpenicillin levels were found to be substantially higher and more prolonged in case of 5 and 9 than of BP itself. However, administration of 13a and 17 resulted in lower brain benzylpenicillin levels due to the water addition reaction and a nonspecific brain delivery, respectively. The remarkable increase of BP levels as well as the prolonged effect after the administration of 5 and 9 is a result of an improved penetration through the blood-brain barrier of the lipophilic CDS's and a "lock-in" effect of the corresponding quaternary salts generated in situ.
基于二氢吡啶-季铵吡啶盐氧化还原体系的四种化学递送系统(CDS)被用于苄青霉素(BP)的脑递送。CDS 5和9是C1和C2二醇的二酯,其中一个羟基被苄青霉素-3-羧基酯化,另一个被二氢胡芦巴碱酯化。CDS 13a和17是氨基醇的苄青霉素酯,其中胺基被二氢胡芦巴碱(13a)或1,2-二氢-2-甲基-4-异喹啉羧酸(17)酰化。体外相对稳定性研究表明,CDS和季铵吡啶盐在大鼠和兔血液或脑中都相当不稳定,但在狗或人血液中更稳定。在大鼠脑匀浆中进行的动力学研究表明,CDS很容易被酶氧化为相应的季铵盐。CDS和季铵盐的水解导致苄青霉素的释放。在生物介质中,CDS 13a还产生了一种加水产物,即6-羟基-1,4,5,6-四氢吡啶衍生物。在大鼠中进行了体内分布研究。静脉注射等摩尔剂量的BP和CDS后,发现对于5和9,脑苄青霉素水平显著更高且持续时间更长,比BP本身的情况要好。然而,分别由于加水反应和非特异性脑递送,给予13a和17导致脑苄青霉素水平较低。给予5和9后BP水平的显著升高以及延长的效果是由于亲脂性CDS对血脑屏障的穿透性提高以及原位生成的相应季铵盐的“锁定”效应。